Terns Pharmaceuticals, Inc. (TERN)

36.58 0.00 (0.00%) USD  |  NASDAQ  |  Jan 21, 12:21
More

Terns Pharmaceuticals Excess Tax Benefit from Stock Compensation (Quarterly)

Excess Tax Benefit from Stock Compensation (Quarterly) Chart

View Excess Tax Benefit from Stock Compensation (Quarterly) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. --
Ligand Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --
Viking Therapeutics, Inc. --
Cidara Therapeutics, Inc. --